CHF68.10
1.64% yesterday
SIX Swiss Exchange, Aug 12, 05:31 pm CET
ISIN
CH0012530207
Symbol
BANB

Bachem Holding Stock price

CHF68.10
+11.70 20.74% 1M
+12.30 22.04% 6M
+10.20 17.62% YTD
-12.40 15.40% 1Y
-1.05 1.52% 3Y
+12.60 22.70% 5Y
+57.86 565.04% 10Y
+54.39 396.56% 20Y
SIX Swiss Exchange, Closing price Tue, Aug 12 2025
+1.10 1.64%

Key metrics

Basic
Market capitalization
CHF5.0b
Enterprise Value
CHF5.1b
Net debt
CHF31.7m
Cash
CHF29.1m
Shares outstanding
75.0m
Valuation (TTM | estimate)
P/E
37.2 | 38.0
P/S
7.4 | 7.0
EV/Sales
7.5 | 7.0
EV/FCF
negative
P/B
3.7
Dividends
DPS
CHF0.85
Yield 1Y | 5Y
1.3% | 0.9%
Growth 1Y | 5Y
6.3% | 7.2%
Payout 1Y | 3Y
53.1% | 53.7%
Increased
6 Years
Financials (TTM | estimate)
Revenue
CHF677.9m | CHF718.2m
EBITDA
CHF204.0m | CHF209.8m
EBIT
CHF164.6m | CHF155.1m
Net Income
CHF134.2m | CHF132.3m
Free Cash Flow
CHF-119.7m
Growth (TTM | estimate)
Revenue
17.3% | 18.7%
EBITDA
14.9% | 19.0%
EBIT
26.6% | 16.6%
Net Income
18.2% | 10.0%
Free Cash Flow
-144.0%
Margin (TTM | estimate)
Gross
31.2%
EBITDA
30.1% | 29.2%
EBIT
24.3%
Net
19.8% | 18.4%
Free Cash Flow
-17.7%
Financial Health
Equity Ratio
72.3%
Return on Equity
8.6%
ROCE
10.2%
ROIC
8.6%
Debt/Equity
0.0
More
EPS
CHF1.8
FCF per Share
CHF-1.6
Short interest
-
Employees
2k
Rev per Employee
CHF270.0k
Show more

Is Bachem Holding a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Bachem Holding Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a Bachem Holding forecast:

10x Buy
67%
5x Hold
33%

Analyst Opinions

15 Analysts have issued a Bachem Holding forecast:

Buy
67%
Hold
33%

Financial data from Bachem Holding

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
678 678
17% 17%
100%
- Direct Costs 466 466
17% 17%
69%
212 212
18% 18%
31%
- Selling and Administrative Expenses 39 39
3% 3%
6%
- Research and Development Expense 9.10 9.10
28% 28%
1%
204 204
15% 15%
30%
- Depreciation and Amortization 39 39
17% 17%
6%
EBIT (Operating Income) EBIT 165 165
27% 27%
24%
Net Profit 134 134
18% 18%
20%

In millions CHF.

Don't miss a Thing! We will send you all news about Bachem Holding directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Bachem Holding AG engages in the provision of peptides and oligonucleotides. It operates through the Europe/Asia and North America geographical segments. It offers project management, research grade production, catalog peptides, peptide NCES, and commercial NCES. The company was founded in 2003 and is headquartered in Bubendorf, Switzerland.

Head office Switzerland
CEO Thomas Meier
Employees 2,207
Founded 2003
Website www.bachem.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today